Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

SPARCL: Stroke Prevention by Aggressive Reduction in Cholesterol Levels

principal contacts

Pierre Amarenco (Denis Diderot University)

K. Michael Welch (Rosalind Franklin University of Medicine and Science)

CTD@Pfizer.com

Data custodian

SPARCL Investigators

Funding

Pfizer Inc.

Key Publications